The offer of $19.60 a share, represents a premium of 83% to the Swedish pharma’s closing price on Monday, and the board has unanimously recommended that shareholders accept the deal.
Government bond issuance by eurozone sovereigns will pick up on Tuesday with the Netherlands, Italy and Germany lining up for auctions, and backflows are supportive of demand, Commerzbank Research said.
The Nikkei Stock Average declined 0.1% to 38855.37 as the 10-year Japanese government bond yield rose 1.5 basis points to 1.035%, the highest level since April 2012.
